Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 12: 747049, 2021.
Article in English | MEDLINE | ID: mdl-34733282

ABSTRACT

Although macrophages are considered for host cells for the multiplication of Leishmania, recent studies indicate the important role of neutrophil granulocytes as host cells for these intracellular parasites. Neutrophils have been shown to be massively and rapidly recruited to the site of Leishmania infection where they represent the first cells to encounter the parasites. Exposure to ATP and UTP have been shown to enhance anti-Leishmania activity of macrophages and intralesional injection of UTP led to strongly reduced parasite load in vivo. Since the in vivo anti-leishmanial effect of extracellular UTP correlated with enhanced neutrophil recruitment and enhanced ROS production at the site of Leishmania infection we hypothesized that exposure to extracellular nucleotides can directly enhance the killing of Leishmania by neutrophils. Since purinergic signaling is an essential mechanism of neutrophil activation the aim of the present study was to assess whether purinergic exposure results in the activation of anti-leishmanial neutrophil functions and, therefore, represent an essential component of enhanced anti-leishmanial defense in leishmaniasis. We could show that exposure to ATP and UTP led to activation and enhanced CD11b expression of primary human neutrophils in vitro. Leishmania-induced ROS production was strongly enhanced by extracellular ATP and UTP. Importantly, exposure to ATP and UTP resulted in enhanced killing of Leishmania donovani by neutrophils. In addition, ATP strongly enhanced the secretion of IL-8 and IL-1ß by Leishmania-exposed neutrophils. Our results suggest that signaling via the P2 receptor and phosphorylation of Erk1/2, Akt and p38 are involved in the purinergic enhancement of anti-leishmanial functions of neutrophils.


Subject(s)
Adenosine Triphosphate/immunology , Leishmania donovani/immunology , Neutrophil Activation/immunology , Neutrophils/immunology , Uridine Triphosphate/immunology , Cells, Cultured , Humans , Leishmaniasis, Visceral/immunology
2.
PLoS One ; 15(3): e0223030, 2020.
Article in English | MEDLINE | ID: mdl-32119673

ABSTRACT

Numerous studies show that various genes in all kinds of organisms are transcribed discontinuously, i.e. in short bursts or pulses with periods of inactivity between them. But it remains unclear whether ribosomal DNA (rDNA), represented by multiple copies in every cell, is also expressed in such manner. In this work, we synchronized the pol I activity in the populations of tumour derived as well as normal human cells by cold block and release. Our experiments with 5-fluorouridine (FU) and BrUTP confirmed that the nucleolar transcription can be efficiently and reversibly arrested at +4°C. Then using special software for analysis of the microscopic images, we measured the intensity of transcription signal (incorporated FU) in the nucleoli at different time points after the release. We found that the ribosomal genes in the human cells are transcribed discontinuously with periods ranging from 45 min to 75 min. Our data indicate that the dynamics of rDNA transcription follows the undulating pattern, in which the bursts are alternated by periods of rare transcription events.


Subject(s)
DNA, Ribosomal/genetics , Ribosomes/genetics , Transcription, Genetic , Aged , Cadaver , Cell Nucleolus/genetics , Cold Temperature , Epithelial Cells/metabolism , HeLa Cells , Humans , Kinetics , Limbus Corneae/cytology , Middle Aged , RNA, Ribosomal/genetics , Software , Transfection , Uridine/analogs & derivatives , Uridine/immunology , Uridine/metabolism , Uridine Triphosphate/analogs & derivatives , Uridine Triphosphate/immunology , Uridine Triphosphate/metabolism
3.
Stem Cell Rev Rep ; 12(1): 121-8, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26400757

ABSTRACT

Successful clinical outcomes from transplantation of hematopoietic stem cells (HSCs) depend upon efficient HSC homing to bone marrow (BM), subsequent engraftment, and, finally, BM repopulation. Homing of intravenously administered HSCs from peripheral blood (PB) through the circulation to the BM stem cell niches, which is the first critical step that precedes their engraftment, is enforced by chemotactic factors released in the BM microenvironment that chemoattract HSCs. These chemotactic factors include α-chemokine stromal-derived factor 1 (SDF-1), the bioactive phosphosphingolipids sphingosine-1-phosphate (S1P) and ceramid-1-phosphate (C1P), and the extracellular nucleotides ATP and UTP. Stem cells may also respond to a Ca(2+) or H(+) gradient by employing calcium- or proton-sensing receptors, respectively. In this review, we will present emerging strategies based on ex vivo manipulation of graft HSCs that are aimed at enhancing the responsiveness of HSCs to BM-secreted chemoattractants and/or promoting HSC adhesion and seeding efficiency in the BM microenvironment.


Subject(s)
Chemotactic Factors/pharmacology , Graft Survival/drug effects , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/drug effects , Stem Cell Niche/drug effects , Adenosine Triphosphate/agonists , Adenosine Triphosphate/immunology , Bone Marrow/drug effects , Bone Marrow/immunology , Ceramides/agonists , Ceramides/immunology , Ceramides/pharmacology , Chemokine CXCL12/agonists , Chemokine CXCL12/immunology , Chemokine CXCL12/pharmacology , Chemotactic Factors/agonists , Chemotactic Factors/immunology , Chemotaxis/drug effects , Dinoprostone/therapeutic use , Hematopoietic Stem Cells/chemistry , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/immunology , Humans , Lysophospholipids/agonists , Lysophospholipids/immunology , Lysophospholipids/pharmacology , Membrane Microdomains/drug effects , Receptors, CXCR4/agonists , Receptors, CXCR4/genetics , Receptors, CXCR4/immunology , Sphingosine/agonists , Sphingosine/analogs & derivatives , Sphingosine/immunology , Sphingosine/pharmacology , Stem Cell Niche/immunology , Uridine Triphosphate/agonists , Uridine Triphosphate/immunology , Valproic Acid/therapeutic use
4.
Microbes Infect ; 16(3): 196-202, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24309427

ABSTRACT

Extracellular nucleotides such as adenosine 5'-triphospate (ATP) and uridine 5'-triphosphate (UTP) interact with P2 purinergic receptors on the surface of phagocytic cells and induce various physiological reactions. In this study, the production of antibody in mice immunized with an inactivated rabies vaccine containing these nucleotides was investigated. Injection of inactivated rabies vaccine with UTP, but not with ATP, induced significantly higher serum antibody production in mice. The enhancement of antibody production by UTP was inhibited by an anti-P2Y4 receptor antibody. In an air pouch experiment, UTP treatment increased the number of monocytes and macrophages infiltrating the pouch and up-regulated the gene expression of IL-4 and IL-13 in the regional lymph nodes. These results suggested that UTP admixed with rabies vaccine activates Th2 cells and induces a humoral immune response. Furthermore, the survival rate of mice immunized with a rabies vaccine admixed with UTP before rabies virus challenge was slightly higher than that of control mice. In conclusion, UTP can act as a vaccine adjuvant to enhance antibody production against the rabies virus in mice.


Subject(s)
Adjuvants, Immunologic/pharmacology , Antibodies, Viral/blood , Rabies Vaccines/immunology , Rabies virus/immunology , Uridine Triphosphate/immunology , Uridine Triphosphate/pharmacology , Adenosine Triphosphate , Adjuvants, Immunologic/chemistry , Animals , Antibody Formation/drug effects , Antibody Formation/immunology , Female , Interleukins/analysis , Interleukins/metabolism , Mice , Mice, Inbred BALB C , Rabies Vaccines/administration & dosage , Rabies Vaccines/chemistry , Rabies Vaccines/pharmacology , Uridine Triphosphate/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...